A single view of all the companies in the same space to infer if the stock is undervalued, overvalued or priced right. This would be one way to analyze a longer terms investment in a particular sector.
| Company | Market Cap | Income | Sales | P/E | P/B | Cash/Share | Dividend | Dividend Yield | Price To Cash Ratio | Debt to Equity Ratio | ROE | ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Aadi Bioscience, Inc. | 363,410,000 | -110,100,000 | 1,100,000 | 0.00 | 2.51 | 6.67 | - | - | 2.44 | 0.04 | -121.80% | -108.70% |
| Arbutus Biopharma Corporation | 395,740,000 | -88,400,000 | 11,000,000 | 0.00 | 2.07 | 1.03 | - | - | 2.55 | 0.00 | -784.30% | -54.20% |
| ABVC BioPharma, Inc. | 75,550,000 | -12,800,000 | 400,000 | 0.00 | 6.71 | 0.18 | - | - | 12.81 | 0.18 | -239.40% | -112.80% |
| ACADIA Pharmaceuticals Inc. | 3,570,000,000 | -167,900,000 | 484,100,000 | 0.00 | 6.10 | 2.96 | - | - | 6.85 | 0.00 | -29.80% | -23.20% |
| Acer Therapeutics Inc. | 34,620,000 | -15,400,000 | 1,300,000 | 0.00 | 0.00 | 0.79 | - | - | 2.73 | 0.00 | -488.50% | -40.10% |
| Adicet Bio, Inc. | 638,010,000 | -62,000,000 | 9,700,000 | 0.00 | 1.63 | 6.32 | - | - | 2.30 | 0.00 | -25.20% | -21.60% |
| AC Immune SA | 336,660,000 | -76,600,000 | 940,000 | 0.00 | 1.29 | 2.36 | - | - | 1.62 | 0.01 | -36.10% | -32.30% |
| Aclaris Therapeutics, Inc. | 980,980,000 | -90,900,000 | 6,800,000 | 0.00 | 4.75 | 2.98 | - | - | 5.13 | 0.00 | -47.80% | -37.70% |
| Acasti Pharma Inc. | 64,910,000 | -14,500,000 | 100,000 | 0.00 | 0.35 | 0.98 | - | - | 1.12 | 0.00 | -13.80% | -13.00% |
| Acurx Pharmaceuticals, Inc. | 40,800,000 | -12,700,000 | 0 | 0.00 | 3.28 | 1.27 | - | - | 3.14 | 0.00 | -114.10% | -104.80% |
| Adagene Inc. | 155,970,000 | -73,200,000 | 10,200,000 | 0.00 | 1.01 | 4.07 | - | - | 0.89 | 0.05 | -167.80% | -50.40% |
| ADC Therapeutics SA | 1,000,000,000 | -230,000,000 | 33,900,000 | 0.00 | 5.85 | 5.89 | - | - | 2.14 | 1.93 | -102.80% | -42.20% |
| Adial Pharmaceuticals, Inc. | 41,300,000 | -19,400,000 | 0 | 0.00 | 9.65 | 0.24 | - | - | 6.77 | 0.00 | -367.30% | -224.50% |
| Addex Therapeutics Ltd | 24,820,000 | 0 | 4,640,000 | 0.00 | 1.86 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Affimed N.V. | 625,160,000 | -62,300,000 | 43,700,000 | 0.00 | 3.38 | 0.00 | - | - | 0.00 | 0.14 | -39.00% | -23.90% |
| Agios Pharmaceuticals, Inc. | 1,480,000,000 | -356,500,000 | 0 | 0.00 | 1.05 | 17.21 | - | - | 1.45 | 0.00 | 95.70% | 87.40% |
| Aeglea BioTherapeutics, Inc. | 94,380,000 | -65,800,000 | 18,700,000 | 0.00 | 1.03 | 1.73 | - | - | 1.01 | 0.00 | -61.40% | -47.90% |
| Akebia Therapeutics, Inc. | 86,780,000 | -282,800,000 | 213,600,000 | 0.00 | 1.07 | 0.81 | - | - | 0.58 | 1.27 | -187.90% | -47.80% |
| Akero Therapeutics, Inc. | 407,460,000 | -100,800,000 | 0 | 0.00 | 2.19 | 4.90 | - | - | 2.16 | 0.00 | -48.30% | -44.10% |
| Akari Therapeutics, Plc | 69,980,000 | -18,500,000 | 0 | 0.00 | 4.67 | 0.21 | - | - | 5.22 | 0.00 | -281.00% | -175.80% |
| Akouos, Inc. | 123,410,000 | -86,700,000 | 0 | 0.00 | 0.49 | 6.27 | - | - | 0.53 | 0.00 | -32.60% | -28.50% |
| Albireo Pharma, Inc. | 706,610,000 | -34,000,000 | 40,600,000 | 0.00 | 3.72 | 11.90 | - | - | 2.85 | 0.00 | -22.00% | -12.70% |
| Aldeyra Therapeutics, Inc. | 216,730,000 | -57,800,000 | 0 | 0.00 | 1.00 | 3.76 | - | - | 0.94 | 0.08 | -29.40% | -26.10% |
| Alkermes plc | 4,860,000,000 | -48,200,000 | 1,170,000,000 | 0.00 | 4.14 | 3.14 | - | - | 9.05 | 0.27 | -4.40% | -2.50% |
| Allakos Inc. | 255,720,000 | -269,900,000 | 0 | 0.00 | 0.53 | 7.13 | - | - | 0.60 | 0.00 | -50.00% | -43.30% |
| Alnylam Pharmaceuticals, Inc. | 19,680,000,000 | -852,800,000 | 844,300,000 | 0.00 | 33.01 | 20.06 | - | - | 8.08 | 1.15 | -109.20% | -24.60% |
| Alpine Immune Sciences, Inc. | 281,950,000 | -50,300,000 | 23,400,000 | 0.00 | 2.27 | 5.37 | - | - | 1.74 | 0.07 | -59.10% | -25.80% |
| Altimmune, Inc. | 218,790,000 | -97,100,000 | 4,400,000 | 0.00 | 1.00 | 4.08 | - | - | 1.15 | 0.00 | -43.30% | -39.70% |
| ALX Oncology Holdings Inc. | 675,720,000 | -83,500,000 | 0 | 0.00 | 1.69 | 8.13 | - | - | 1.86 | 0.00 | -21.20% | -20.40% |
| Alzamend Neuro, Inc. | 93,270,000 | -9,700,000 | 0 | 0.00 | 7.38 | 0.12 | - | - | 7.90 | 0.00 | -92.10% | -83.60% |
| Amarin Corporation plc | 1,250,000,000 | 7,700,000 | 583,200,000 | 177.65 | 1.80 | 1.10 | - | - | 2.75 | 0.00 | 1.20% | 0.70% |
| Applied Molecular Transport Inc. | 183,510,000 | -100,300,000 | 0 | 0.00 | 1.08 | 4.00 | - | - | 1.15 | 0.00 | -59.60% | -52.00% |
| AnaptysBio, Inc. | 652,270,000 | -57,800,000 | 63,200,000 | 0.00 | 1.81 | 19.73 | - | - | 1.19 | 0.00 | -15.30% | -12.20% |
| Anebulo Pharmaceuticals, Inc. | 107,150,000 | -40,500,000 | 0 | 0.00 | 5.23 | 0.71 | - | - | 5.95 | 0.00 | -319.00% | -247.70% |
| Angion Biomedica Corp. | 46,600,000 | -54,600,000 | 28,300,000 | 0.00 | 0.52 | 2.69 | - | - | 0.52 | 0.00 | -69.20% | -46.30% |
| Annexon, Inc. | 109,040,000 | -130,300,000 | 0 | 0.00 | 0.43 | 5.83 | - | - | 0.45 | 0.00 | -46.80% | -41.30% |
| Annovis Bio, Inc. | 106,580,000 | -14,500,000 | 0 | 0.00 | 2.15 | 5.06 | - | - | 2.33 | 0.00 | -40.20% | -38.90% |
| Apellis Pharmaceuticals, Inc. | 5,680,000,000 | -746,400,000 | 66,599,999 | 0.00 | 22.87 | 6.09 | - | - | 8.11 | 2.73 | - | -102.30% |
| Applied Therapeutics, Inc. | 52,940,000 | -105,600,000 | 0 | 0.00 | 0.83 | 3.07 | - | - | 0.66 | 0.00 | -106.40% | -84.20% |
| Aptorum Group Limited | 45,610,000 | -3,600,000 | 1,200,000 | 0.00 | 1.39 | 0.58 | - | - | 2.21 | 0.04 | -13.00% | -11.60% |
| Aprea Therapeutics, Inc. | 36,330,000 | -37,100,000 | 0 | 0.00 | 0.69 | 2.32 | - | - | 0.68 | 0.00 | -63.70% | -54.70% |
| Aptinyx Inc. | 73,830,000 | -74,900,000 | 1,000,000 | 0.00 | 0.73 | 1.47 | - | - | 0.70 | 0.15 | -61.60% | -56.00% |
| Aptevo Therapeutics Inc. | 23,990,000 | -29,400,000 | 12,300,000 | 0.00 | 18.56 | 8.70 | - | - | 0.53 | 12.83 | -346.10% | -43.60% |
| Aquestive Therapeutics, Inc. | 84,330,000 | -70,500,000 | 50,800,000 | 0.00 | 0.00 | 0.63 | - | - | 3.01 | 0.00 | 113.80% | -110.20% |
| Aravive, Inc. | 47,780,000 | -39,200,000 | 7,400,000 | 0.00 | 0.79 | 1.96 | - | - | 0.80 | 0.00 | -68.30% | -49.40% |
| Arcturus Therapeutics Holdings Inc. | 670,650,000 | -203,700,000 | 12,400,000 | 0.00 | 2.55 | 12.20 | - | - | 1.81 | 0.28 | -71.10% | -46.40% |
| Aridis Pharmaceuticals, Inc. | 23,560,000 | -46,300,000 | 1,500,000 | 0.00 | 0.00 | 0.98 | - | - | 1.30 | 0.00 | 471.40% | -226.40% |
| 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Arcutis Biotherapeutics, Inc. | 1,120,000,000 | -206,400,000 | 0 | 0.00 | 3.59 | 7.32 | - | - | 2.91 | 0.24 | -54.10% | -48.60% |
| Arvinas, Inc. | 3,560,000,000 | -191,000,000 | 46,700,000 | 0.00 | 4.27 | 26.69 | - | - | 2.37 | 0.00 | -27.30% | -16.90% |
| Arrowhead Pharmaceuticals, Inc. | 4,970,000,000 | -183,000,000 | 144,400,000 | 0.00 | 12.33 | 2.92 | - | - | 15.05 | 0.00 | -44.00% | -25.80% |
| ASLAN Pharmaceuticals Limited | 52,500,000 | -21,300,000 | 0 | 0.00 | 0.65 | 1.25 | - | - | 0.56 | 0.21 | -63.80% | -37.50% |
| Assembly Biosciences, Inc. | 100,000,000 | -129,900,000 | 6,300,000 | 0.00 | 0.56 | 3.08 | - | - | 0.68 | 0.00 | -59.50% | -52.90% |
| Ascendis Pharma A/S | 6,370,000,000 | -415,600,000 | 8,400,000 | 0.00 | 6.43 | 12.56 | - | - | 8.62 | 0.12 | -45.60% | -37.40% |
| Atai Life Sciences N.V. | 850,520,000 | -167,800,000 | 20,400,000 | 0.00 | 1.98 | 2.12 | - | - | 2.35 | 0.00 | - | - |
| 180 Life Sciences Corp. | 61,270,000 | -20,300,000 | 0 | 0.00 | 1.44 | 0.22 | - | - | 7.47 | 0.05 | -79.80% | -33.30% |
| Actinium Pharmaceuticals, Inc. | 159,430,000 | -24,800,000 | 1,100,000 | 0.00 | 2.09 | 3.39 | - | - | 2.05 | 0.00 | -32.50% | -30.50% |
| Atossa Therapeutics, Inc. | 132,960,000 | -20,600,000 | 0 | 0.00 | 0.96 | 1.08 | - | - | 0.97 | 0.00 | -14.70% | -14.40% |
| Astria Therapeutics, Inc. | 82,510,000 | -219,300,000 | 0 | 0.00 | 3.17 | 9.54 | - | - | 0.66 | 0.00 | - | -158.90% |
| Aurinia Pharmaceuticals Inc. | 1,720,000,000 | -181,000,000 | 45,600,000 | 0.00 | 3.16 | 3.09 | - | - | 3.69 | 0.00 | -48.90% | -42.40% |
| AVEO Pharmaceuticals, Inc. | 186,220,000 | -53,300,000 | 42,300,000 | 0.00 | 3.86 | 2.40 | - | - | 2.13 | 0.83 | -92.90% | -46.90% |
| Atea Pharmaceuticals, Inc. | 549,190,000 | 121,200,000 | 351,400,000 | 4.51 | 0.72 | 8.53 | - | - | 0.72 | 0.00 | 19.60% | 14.60% |
| Aerovate Therapeutics, Inc. | 424,380,000 | -23,000,000 | 0 | 0.00 | 1.97 | 5.80 | - | - | 2.54 | 0.00 | -29.20% | -21.30% |
| Axsome Therapeutics, Inc. | 1,290,000,000 | -130,400,000 | 0 | 0.00 | 74.39 | 2.04 | - | - | 14.93 | 0.00 | -230.70% | -101.40% |
| BridgeBio Pharma, Inc. | 1,600,000,000 | -562,500,000 | 69,700,000 | 0.00 | 0.00 | 5.27 | - | - | 1.92 | 0.00 | 91.00% | -56.70% |
| Atreca, Inc. | 96,180,000 | -109,300,000 | 0 | 0.00 | 0.58 | 2.90 | - | - | 0.82 | 0.00 | -58.30% | -47.40% |
| BriaCell Therapeutics Corp. | 112,820,000 | 0 | 0 | 0.00 | 1.97 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Bicycle Therapeutics plc | 807,690,000 | -66,800,000 | 11,700,000 | 0.00 | 2.16 | 13.95 | - | - | 1.84 | 0.09 | -33.40% | -22.10% |
| 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| BeiGene, Ltd. | 19,170,000,000 | -1,413,400,000 | 1,180,000,000 | 0.00 | 2.48 | 56.21 | - | - | 2.90 | 0.10 | -32.80% | -22.40% |
| Biohaven Pharmaceutical Holding Company Ltd. | 7,540,000,000 | -846,600,000 | 462,500,000 | 0.00 | 0.00 | 5.30 | - | - | 20.69 | 0.00 | 164.60% | -83.50% |
| BioVie Inc. | 110,950,000 | -145,500,000 | 0 | 0.00 | 6.28 | 1.10 | - | - | 3.65 | 0.00 | - | -799.40% |
| Bellicum Pharmaceuticals, Inc. | 17,290,000 | -9,700,000 | 6,200,000 | 0.00 | 1.13 | 4.68 | - | - | 0.37 | 0.00 | 261.00% | -30.60% |
| Bellerophon Therapeutics, Inc. | 19,440,000 | -17,800,000 | 0 | 0.00 | 0.82 | 2.36 | - | - | 0.79 | 0.00 | -64.20% | -51.70% |
| BioLineRx Ltd. | 74,050,000 | -27,100,000 | 0 | 0.00 | 0.99 | 1.09 | - | - | 1.30 | 0.07 | -39.00% | -31.50% |
| BELLUS Health Inc. | 983,240,000 | -71,200,000 | 20,000 | 0.00 | 2.46 | 2.21 | - | - | 3.95 | 0.00 | -44.70% | -41.40% |
| Biomea Fusion, Inc. | 120,260,000 | -41,600,000 | 0 | 0.00 | 0.53 | 4.70 | - | - | 0.69 | 0.00 | -29.10% | -25.40% |
| BioMarin Pharmaceutical Inc. | 15,160,000,000 | -68,000,000 | 1,850,000,000 | 0.00 | 3.52 | 5.48 | - | - | 14.95 | 0.00 | -1.50% | -1.10% |
| Benitec Biopharma Inc. | 16,129,999 | -17,800,000 | 0 | 0.00 | 1.47 | 0.00 | - | - | 0.00 | 0.00 | -124.20% | -106.70% |
| Bolt Biotherapeutics, Inc. | 74,300,000 | -98,600,000 | 1,300,000 | 0.00 | 0.27 | 4.49 | - | - | 0.40 | 0.00 | -35.10% | -30.00% |
| Blueprint Medicines Corporation | 4,099,999,999 | -644,100,000 | 180,100,000 | 0.00 | 3.96 | 7.58 | - | - | 8.59 | 0.00 | -52.10% | -43.50% |
| Bio-Path Holdings, Inc. | 21,240,000 | -10,400,000 | 0 | 0.00 | 0.82 | 3.26 | - | - | 0.89 | 0.00 | -36.00% | -34.40% |
| Biophytis SA | 21,280,000 | 0 | 0 | 0.00 | 3.06 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| BioXcel Therapeutics, Inc. | 431,580,000 | -106,900,000 | 0 | 0.00 | 1.85 | 7.89 | - | - | 1.85 | 0.00 | -46.40% | -43.50% |
| Brooklyn ImmunoTherapeutics, Inc. | 74,470,000 | -122,300,000 | 0 | 0.00 | 9.92 | 0.27 | - | - | 4.38 | 0.00 | -972.70% | -311.20% |
| BeyondSpring Inc. | 73,170,000 | -64,200,000 | 1,400,000 | 0.00 | 2.88 | 1.94 | - | - | 1.01 | 0.06 | -133.10% | -71.40% |
| Calliditas Therapeutics AB (publ) | 433,650,000 | 0 | 0 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Can-Fite BioPharma Ltd. | 20,270,000 | 0 | 800,000 | 0.00 | 2.10 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Capricor Therapeutics, Inc. | 82,820,000 | -20,000,000 | 200,000 | 0.00 | 2.55 | 1.39 | - | - | 2.37 | 0.11 | -58.10% | -47.70% |
| Cara Therapeutics, Inc. | 663,660,000 | -88,400,000 | 23,000,000 | 0.00 | 2.67 | 2.90 | - | - | 3.97 | 0.00 | -40.70% | -37.50% |
| CymaBay Therapeutics, Inc. | 246,580,000 | -90,000,000 | 0 | 0.00 | 1.51 | 1.97 | - | - | 1.32 | 0.38 | -79.20% | -62.20% |
| ChemoCentryx, Inc. | 1,510,000,000 | -131,800,000 | 32,200,000 | 0.00 | 4.86 | 3.47 | - | - | 5.73 | 0.08 | -40.80% | -28.50% |
| Avid Bioservices, Inc. | 1,100,000,000 | 9,800,000 | 116,000,000 | 110.20 | 18.21 | 2.29 | - | - | 7.31 | 2.51 | 17.00% | 3.40% |
| Celularity Inc. | 1,640,000,000 | -100,100,000 | 21,300,000 | 0.00 | 14.29 | 0.26 | - | - | 43.98 | 0.31 | -75.70% | -31.20% |
| Cerevel Therapeutics Holdings, Inc. | 5,180,000,000 | -225,300,000 | 0 | 0.00 | 8.26 | 3.55 | - | - | 9.16 | 0.00 | -48.90% | -40.60% |
| ContraFect Corporation | 173,700,000 | -20,300,000 | 0 | 0.00 | 3.09 | 1.21 | - | - | 3.20 | 0.00 | -36.60% | -24.70% |
| Checkpoint Therapeutics, Inc. | 122,220,000 | -56,700,000 | 300,000 | 0.00 | 3.57 | 0.59 | - | - | 2.23 | 0.00 | -120.10% | -92.80% |
| Clene Inc. | 191,980,000 | -9,700,000 | 700,000 | 0.00 | 14.50 | 0.76 | - | - | 3.82 | 1.53 | 89.10% | -14.50% |
| Clearside Biomedical, Inc. | 124,230,000 | 400,000 | 29,600,000 | 0.00 | 2.70 | 0.42 | - | - | 4.09 | 0.00 | 1.60% | 1.20% |
| Clovis Oncology, Inc. | 348,720,000 | -264,500,000 | 148,800,000 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | 113.50% | -50.30% |
| Chemomab Therapeutics Ltd. | 42,970,000 | -12,500,000 | 0 | 0.00 | 0.04 | 1.21 | - | - | 2.83 | 0.00 | -20.00% | -19.00% |
| Chimerix, Inc. | 439,550,000 | -173,200,000 | 2,000,000 | 0.00 | 6.35 | 1.01 | - | - | 4.97 | 0.20 | -162.80% | -128.50% |
| Concert Pharmaceuticals, Inc. | 120,870,000 | -80,100,000 | 32,600,000 | 0.00 | 1.04 | 3.89 | - | - | 0.84 | 0.00 | -71.50% | -55.00% |
| Centessa Pharmaceuticals Limited | 885,900,000 | -381,100,000 | 0 | 0.00 | 1.69 | 6.08 | - | - | 1.49 | 0.15 | -92.00% | -69.10% |
| Connect Biopharma Holdings Limited | 151,760,000 | 0 | 0 | 0.00 | 0.07 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Cogent Biosciences, Inc. | 324,790,000 | -72,300,000 | 0 | 0.00 | 2.29 | 4.80 | - | - | 1.48 | 0.00 | -57.80% | -31.60% |
| Corcept Therapeutics Incorporated | 2,480,000,000 | 112,500,000 | 366,000,000 | 25.40 | 6.90 | 2.05 | - | - | 11.11 | 0.00 | 23.10% | 21.10% |
| CorMedix Inc. | 174,780,000 | -28,200,000 | 200,000 | 0.00 | 2.46 | 1.52 | - | - | 2.67 | 0.00 | -39.00% | -36.50% |
| Crinetics Pharmaceuticals, Inc. | 1,300,000,000 | -107,600,000 | 1,100,000 | 0.00 | 3.02 | 5.68 | - | - | 3.90 | 0.00 | -49.10% | -45.80% |
| Corvus Pharmaceuticals, Inc. | 63,330,000 | -43,200,000 | 0 | 0.00 | 0.65 | 1.48 | - | - | 0.91 | 0.00 | -44.00% | -38.70% |
| CTI BioPharma Corp. | 516,610,000 | -97,900,000 | 0 | 0.00 | 131.00 | 0.66 | - | - | 7.90 | 12.47 | -298.90% | -133.20% |
| CytomX Therapeutics, Inc. | 137,790,000 | -83,600,000 | 69,600,000 | 0.00 | 1.43 | 4.34 | - | - | 0.45 | 0.00 | -70.00% | -21.60% |
| Citius Pharmaceuticals, Inc. | 183,710,000 | -25,600,000 | 0 | 0.00 | 1.31 | 0.40 | - | - | 2.81 | 0.00 | -19.80% | -18.20% |
| Cue Biopharma, Inc. | 144,870,000 | -44,200,000 | 14,900,000 | 0.00 | 2.15 | 1.96 | - | - | 2.25 | 0.00 | -65.00% | -51.90% |
| CureVac N.V. | 3,340,000,000 | 0 | 73,500,000 | 0.00 | 4.55 | 5.87 | - | - | 2.88 | 0.08 | - | - |
| Celyad Oncology SA | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Cyclacel Pharmaceuticals, Inc. | 20,920,000 | -19,100,000 | 0 | 0.00 | 0.54 | 3.50 | - | - | 0.57 | 0.00 | -44.90% | -41.10% |
| Cyclerion Therapeutics, Inc. | 36,880,000 | -51,600,000 | 3,900,000 | 0.00 | 0.72 | 1.17 | - | - | 0.68 | 0.00 | -94.60% | -68.20% |
| Cyteir Therapeutics, Inc. | 125,610,000 | -42,100,000 | 0 | 0.00 | 0.62 | 4.92 | - | - | 0.66 | 0.00 | -32.10% | -24.40% |
| Cytokinetics, Incorporated | 3,290,000,000 | -215,300,000 | 70,400,000 | 0.00 | 12.59 | 5.24 | - | - | 6.97 | 0.00 | -149.20% | -30.60% |
| Altamira Therapeutics Ltd. | 14,840,000 | -18,200,000 | 0 | 0.00 | 1.01 | 0.06 | - | - | 14.84 | 0.00 | -128.70% | -97.50% |
| Dare Bioscience, Inc. | 107,200,000 | -38,700,000 | 0 | 0.00 | 1.65 | 0.59 | - | - | 2.07 | 0.00 | -189.60% | -119.10% |
| Day One Biopharmaceuticals, Inc. | 694,680,000 | -183,100,000 | 0 | 0.00 | 2.04 | 4.53 | - | - | 2.34 | 0.00 | - | - |
| Decibel Therapeutics, Inc. | 54,870,000 | -54,100,000 | 0 | 0.00 | 0.38 | 5.91 | - | - | 0.37 | 0.00 | -33.50% | -28.00% |
| Deciphera Pharmaceuticals, Inc. | 644,090,000 | -300,000,000 | 96,100,000 | 0.00 | 2.14 | 4.94 | - | - | 2.25 | 0.00 | -73.40% | -58.60% |
| DiaMedica Therapeutics Inc. | 60,300,000 | -13,600,000 | 0 | 0.00 | 1.36 | 1.68 | - | - | 1.34 | 0.00 | -40.40% | -38.70% |
| Dermata Therapeutics, Inc. | 10,410,000 | -10,500,000 | 0 | 0.00 | 1.02 | 1.28 | - | - | 0.96 | 0.00 | -183.70% | -149.00% |
| Bright Minds Biosciences Inc. | 17,480,000 | -12,800,000 | 0 | 0.00 | 0.90 | 0.98 | - | - | 1.16 | 0.00 | -63.00% | -61.60% |
| Design Therapeutics, Inc. | 816,080,000 | -35,500,000 | 30,000 | 0.00 | 1.96 | 6.34 | - | - | 2.12 | 0.00 | -9.00% | -8.80% |
| Dynavax Technologies Corporation | 1,330,000,000 | 72,100,000 | 439,400,000 | 32.31 | 5.44 | 4.09 | - | - | 2.43 | 0.99 | 61.00% | 9.30% |
| Dyne Therapeutics, Inc. | 476,340,000 | -149,300,000 | 0 | 0.00 | 1.23 | 6.96 | - | - | 1.27 | 0.00 | -34.90% | -32.30% |
| Edesa Biotech, Inc. | 40,060,000 | -15,100,000 | 0 | 0.00 | 3.09 | 0.36 | - | - | 6.79 | 0.00 | -102.80% | -89.00% |
| eFFECTOR Therapeutics, Inc. | 159,210,000 | 15,800,000 | 1,400,000 | 0.00 | 8.09 | 1.09 | - | - | 3.20 | 1.09 | 18.70% | 13.50% |
| Eledon Pharmaceuticals, Inc. | 42,080,000 | -34,500,000 | 0 | 0.00 | 0.26 | 5.88 | - | - | 0.50 | 0.00 | -19.80% | -19.10% |
| Eliem Therapeutics, Inc. | 84,840,000 | -52,000,000 | 0 | 0.00 | 0.45 | 4.63 | - | - | 0.62 | 0.00 | -83.30% | -40.30% |
| Enlivex Therapeutics Ltd. | 111,710,000 | -15,600,000 | 0 | 0.00 | 1.25 | 4.70 | - | - | 1.28 | 0.00 | -20.50% | -18.90% |
| Enochian Biosciences, Inc. | 372,280,000 | -38,400,000 | 0 | 0.00 | 2.24 | 0.26 | - | - | 27.17 | 0.04 | -22.90% | -21.00% |
| Ensysce Biosciences, Inc. | 25,560,000 | 2,900,000 | 0 | 2.32 | 3.47 | 0.00 | - | - | 0.00 | 0.26 | 107.10% | 22.50% |
| Enanta Pharmaceuticals, Inc. | 1,580,000,000 | -100,800,000 | 93,000,000 | 0.00 | 3.71 | 11.49 | - | - | 6.09 | 0.00 | -24.60% | -22.40% |
| ESSA Pharma Inc. | 283,910,000 | -39,400,000 | 0 | 0.00 | 1.38 | 3.93 | - | - | 1.50 | 0.00 | -20.00% | -19.60% |
| Epizyme, Inc. | 136,060,000 | -251,100,000 | 37,400,000 | 0.00 | 0.00 | 1.01 | - | - | 0.77 | 0.00 | - | -72.80% |
| Equillium, Inc. | 100,780,000 | -39,100,000 | 0 | 0.00 | 1.28 | 2.32 | - | - | 1.25 | 0.15 | -49.00% | -40.60% |
| EQRx, Inc. | 2,570,000,000 | -100,000,000 | 0 | 0.00 | 1.53 | 3.23 | - | - | 1.53 | 0.00 | - | - |
| Erasca, Inc. | 1,110,000,000 | -122,800,000 | 0 | 0.00 | 2.22 | 3.18 | - | - | 2.67 | 0.00 | -74.40% | -33.70% |
| Esperion Therapeutics, Inc. | 326,820,000 | -269,100,000 | 78,400,000 | 0.00 | 0.00 | 4.13 | - | - | 1.26 | 0.00 | 95.00% | -92.30% |
| 89bio, Inc. | 59,750,000 | -90,100,000 | 0 | 0.00 | 0.44 | 6.96 | - | - | 0.40 | 0.15 | -56.70% | -50.70% |
| Eton Pharmaceuticals, Inc. | 97,520,000 | -2,000,000 | 21,800,000 | 0.00 | 5.41 | 0.56 | - | - | 6.77 | 0.38 | -10.30% | -6.80% |
| Entasis Therapeutics Holdings Inc. | 90,650,000 | -47,100,000 | 0 | 0.00 | 2.90 | 0.00 | - | - | 0.00 | 0.00 | -111.10% | -90.60% |
| Edgewise Therapeutics, Inc. | 408,890,000 | -42,800,000 | 0 | 0.00 | 1.56 | 5.93 | - | - | 1.46 | 0.00 | -14.70% | -14.30% |
| Eyenovia, Inc. | 80,350,000 | -12,800,000 | 14,000,000 | 0.00 | 3.34 | 0.59 | - | - | 4.12 | 0.35 | -111.50% | -44.00% |
| Fortress Biotech, Inc. | 116,000,000 | -64,700,000 | 68,800,000 | 0.00 | 0.82 | 2.79 | - | - | 0.38 | 0.47 | -62.30% | -16.00% |
| Forte Biosciences, Inc. | 20,860,000 | -21,700,000 | 0 | 0.00 | 0.47 | 2.64 | - | - | 0.50 | 0.00 | -45.70% | -43.30% |
| FibroGen, Inc. | 1,010,000,000 | -290,000,000 | 235,300,000 | 0.00 | 4.63 | 4.19 | - | - | 2.49 | 0.08 | -99.40% | -36.00% |
| Foghorn Therapeutics Inc. | 561,370,000 | -101,300,000 | 1,300,000 | 0.00 | 5.07 | 3.55 | - | - | 3.64 | 0.00 | -99.50% | -35.40% |
| Homology Medicines, Inc. | 112,680,000 | -95,800,000 | 34,000,000 | 0.00 | 0.61 | 2.52 | - | - | 0.72 | 0.00 | -48.30% | -40.90% |
| Amicus Therapeutics, Inc. | 2,310,000,000 | -250,500,000 | 305,500,000 | 0.00 | 7.32 | 1.63 | - | - | 4.79 | 1.27 | -87.20% | -29.00% |
| Frequency Therapeutics, Inc. | 60,040,000 | -84,700,000 | 14,100,000 | 0.00 | 0.41 | 3.35 | - | - | 0.46 | 0.11 | -54.50% | -39.90% |
| F-star Therapeutics, Inc. | 68,450,000 | -31,300,000 | 21,200,000 | 0.00 | 0.65 | 0.00 | - | - | 0.00 | 0.00 | -39.00% | -30.10% |
| Fulcrum Therapeutics, Inc. | 486,720,000 | -80,800,000 | 19,200,000 | 0.00 | 2.10 | 4.90 | - | - | 2.23 | 0.00 | -47.50% | -41.20% |
| First Wave BioPharma, Inc. | 11,960,000 | -84,500,000 | 0 | 0.00 | 0.00 | 0.47 | - | - | 1.46 | 0.00 | - | -604.00% |
| Forward Pharma A/S | 42,320,000 | -1,900,000 | 0 | 0.00 | 0.58 | 9.82 | - | - | 0.60 | 0.00 | -2.50% | -2.50% |
| Galectin Therapeutics Inc. | 102,110,000 | -30,700,000 | 0 | 0.00 | 168.00 | 0.65 | - | - | 2.58 | 72.50 | -321.30% | -90.20% |
| Gain Therapeutics, Inc. | 45,370,000 | -13,900,000 | 200,000 | 0.00 | 1.18 | 2.81 | - | - | 1.23 | 0.02 | -35.10% | -31.80% |
| Generation Bio Co. | 417,960,000 | -119,200,000 | 0 | 0.00 | 0.99 | 6.17 | - | - | 1.11 | 0.00 | -28.40% | -24.50% |
| Global Blood Therapeutics, Inc. | 2,420,000,000 | -303,100,000 | 194,700,000 | 0.00 | 11.46 | 9.88 | - | - | 3.53 | 2.96 | -102.40% | -43.10% |
| Geron Corporation | 515,020,000 | -116,100,000 | 1,400,000 | 0.00 | 4.16 | 0.56 | - | - | 2.80 | 0.39 | -70.90% | -48.10% |
| GH Research PLC | 940,320,000 | -9,200,000 | 0 | 0.00 | 1.11 | 4.86 | - | - | 3.40 | 0.00 | -4.30% | -4.30% |
| Galmed Pharmaceuticals Ltd. | 39,000,000 | -35,300,000 | 0 | 0.00 | 1.03 | 1.67 | - | - | 0.93 | 0.00 | -78.50% | -67.40% |
| Galapagos NV | 4,190,000,000 | 0 | 526,200,000 | 0.00 | 1.60 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Greenwich LifeSciences, Inc. | 201,430,000 | -4,600,000 | 0 | 0.00 | 7.77 | 2.12 | - | - | 7.41 | 0.00 | -16.00% | -15.70% |
| Galecto, Inc. | 51,960,000 | -51,800,000 | 0 | 0.00 | 0.41 | 3.64 | - | - | 0.52 | 0.00 | -38.30% | -36.70% |
| GlycoMimetics, Inc. | 49,490,000 | -63,400,000 | 1,200,000 | 0.00 | 0.57 | 1.63 | - | - | 0.55 | 0.00 | -61.00% | -54.60% |
| Genmab A/S | 24,730,000,000 | 438,100,000 | 1,240,000,000 | 54.43 | 7.31 | 4.11 | - | - | 8.78 | 0.02 | 14.40% | 12.90% |
| Gemini Therapeutics, Inc. | 72,870,000 | -71,900,000 | 0 | 0.00 | 0.54 | 2.92 | - | - | 0.53 | 0.04 | -48.40% | -43.70% |
| Genprex, Inc. | 89,130,000 | -19,600,000 | 0 | 0.00 | 1.94 | 0.72 | - | - | 2.31 | 0.00 | -42.50% | -41.50% |
| Gossamer Bio, Inc. | 686,540,000 | -234,000,000 | 0 | 0.00 | 5.64 | 4.30 | - | - | 2.11 | 1.47 | -119.40% | -56.90% |
| GeoVax Labs, Inc. | 7,020,000 | -18,600,000 | 400,000 | 0.00 | 1.26 | 1.40 | - | - | 0.62 | 0.00 | -119.00% | -104.50% |
| Gracell Biotechnologies Inc. | 146,480,000 | -65,900,000 | 370,000 | 0.00 | 0.50 | 4.70 | - | - | 0.48 | 0.06 | -30.10% | -21.70% |
| Galera Therapeutics, Inc. | 52,990,000 | -80,500,000 | 0 | 0.00 | 0.00 | 2.56 | - | - | 0.74 | 0.00 | 234.70% | -87.60% |
| GT Biopharma, Inc. | 74,040,000 | -58,000,000 | 0 | 0.00 | 3.38 | 0.92 | - | - | 2.31 | 0.00 | -202.50% | -171.70% |
| G1 Therapeutics, Inc. | 299,460,000 | -148,400,000 | 31,500,000 | 0.00 | 1.90 | 4.73 | - | - | 1.35 | 0.52 | -76.00% | -54.80% |
| HCW Biologics Inc. | 87,870,000 | -12,900,000 | 4,099,999 | 0.00 | 0.88 | 1.01 | - | - | 2.39 | 0.00 | -83.10% | -37.90% |
| Hepion Pharmaceuticals, Inc. | 80,280,000 | -32,700,000 | 0 | 0.00 | 0.82 | 1.12 | - | - | 0.88 | 0.00 | -31.40% | -28.50% |
| Humanigen, Inc. | 164,540,000 | -236,600,000 | 3,600,000 | 0.00 | 0.00 | 0.91 | - | - | 2.35 | 0.00 | - | -256.10% |
| HOOKIPA Pharma Inc. | 96,130,000 | -75,700,000 | 18,400,000 | 0.00 | 0.58 | 1.09 | - | - | 1.46 | 0.06 | -65.30% | -50.10% |
| Werewolf Therapeutics, Inc. | 113,170,000 | -201,900,000 | 0 | 0.00 | 0.75 | 5.80 | - | - | 0.72 | 0.00 | -230.80% | -126.70% |
| Harmony Biosciences Holdings, Inc. | 3,020,000,000 | 34,600,000 | 305,400,000 | 87.01 | 15.73 | 3.89 | - | - | 12.87 | 1.03 | 24.20% | 9.10% |
| Heron Therapeutics, Inc. | 581,440,000 | -220,700,000 | 86,300,000 | 0.00 | 7.04 | 1.45 | - | - | 3.69 | 1.92 | -159.70% | -64.30% |
| Intercept Pharmaceuticals, Inc. | 500,390,000 | -91,400,000 | 363,500,000 | 0.00 | 0.00 | 14.03 | - | - | 1.19 | 0.00 | 49.20% | -17.50% |
| IDEAYA Biosciences, Inc. | 434,420,000 | -49,800,000 | 27,900,000 | 0.00 | 1.45 | 6.42 | - | - | 1.76 | 0.00 | -18.20% | -13.90% |
| InflaRx N.V. | 80,760,000 | -49,400,000 | 0 | 0.00 | 0.69 | 1.99 | - | - | 0.89 | 0.01 | -37.80% | -34.00% |
| IGM Biosciences, Inc. | 782,750,000 | -165,200,000 | 0 | 0.00 | 2.52 | 5.36 | - | - | 3.41 | 0.00 | -54.70% | -48.50% |
| I-Mab | 1,140,000,000 | -361,500,000 | 13,600,000 | 0.00 | 1.40 | 7.36 | - | - | 1.72 | 0.00 | -48.00% | -41.60% |
| ImmunoGen, Inc. | 1,180,000,000 | -139,300,000 | 69,900,000 | 0.00 | 3.52 | 2.11 | - | - | 2.46 | 0.00 | -98.60% | -37.90% |
| Imago BioSciences, Inc. | 703,650,000 | -42,300,000 | 0 | 0.00 | 3.14 | 6.19 | - | - | 3.24 | 0.00 | -59.70% | -26.40% |
| Immutep Limited | 175,070,000 | 0 | 3,860,000 | 0.00 | 2.39 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Immunome, Inc. | 55,720,000 | -24,700,000 | 0 | 0.00 | 1.01 | 3.53 | - | - | 1.13 | 0.00 | -49.10% | -43.50% |
| Impel NeuroPharma, Inc. | 146,470,000 | -76,700,000 | 700,000 | 0.00 | 2.67 | 3.64 | - | - | 1.66 | 0.56 | -869.10% | -102.20% |
| IMARA Inc. | 36,810,000 | -51,400,000 | 0 | 0.00 | 0.44 | 3.53 | - | - | 0.41 | 0.00 | -63.10% | -57.90% |
| Immuneering Corporation | 174,750,000 | -33,500,000 | 2,100,000 | 0.00 | 1.00 | 5.08 | - | - | 1.17 | 0.00 | -53.50% | -32.20% |
| Immunic, Inc. | 216,840,000 | -92,900,000 | 0 | 0.00 | 1.95 | 3.31 | - | - | 2.50 | 0.00 | -70.00% | -63.40% |
| IMV Inc. | 133,810,000 | -46,000,000 | 200,000 | 0.00 | 3.73 | 0.45 | - | - | 2.75 | 0.91 | -145.50% | -85.00% |
| Indaptus Therapeutics, Inc. | 27,440,000 | -7,700,000 | 0 | 0.00 | 0.73 | 4.53 | - | - | 0.70 | 0.00 | -31.10% | -25.30% |
| Infinity Pharmaceuticals, Inc. | 75,550,000 | -45,300,000 | 1,900,000 | 0.00 | 3.56 | 0.91 | - | - | 0.94 | 0.00 | -122.90% | -45.90% |
| InMed Pharmaceuticals Inc. | 11,590,000 | 0 | 270,000 | 0.00 | 0.56 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Insmed Incorporated | 3,070,000,000 | -434,700,000 | 188,500,000 | 0.00 | 6.81 | 5.49 | - | - | 4.29 | 1.42 | -105.50% | -38.80% |
| Innoviva, Inc. | 1,270,000,000 | 265,899,999 | 391,900,000 | 6.41 | 2.97 | 0.00 | - | - | 0.00 | 0.95 | 59.70% | 28.80% |
| Inozyme Pharma, Inc. | 168,910,000 | -56,600,000 | 0 | 0.00 | 1.11 | 3.39 | - | - | 1.51 | 0.00 | -43.40% | -39.80% |
| Ionis Pharmaceuticals, Inc. | 6,180,000,000 | -28,600,000 | 810,500,000 | 0.00 | 7.74 | 14.49 | - | - | 2.92 | 1.59 | -4.50% | -1.20% |
| IVERIC bio, Inc. | 1,980,000,000 | -114,500,000 | 0 | 0.00 | 4.74 | 2.86 | - | - | 5.19 | 0.00 | -51.30% | -46.30% |
| Intra-Cellular Therapies, Inc. | 5,700,000,000 | -284,100,000 | 83,800,000 | 0.00 | 10.37 | 3.85 | - | - | 13.82 | 0.00 | -54.90% | -48.40% |
| Inventiva S.A. | 407,830,000 | 0 | 5,640,000 | 0.00 | 4.37 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Janux Therapeutics, Inc. | 593,760,000 | -32,700,000 | 3,600,000 | 0.00 | 1.49 | 8.32 | - | - | 1.58 | 0.00 | -11.80% | -10.50% |
| Jazz Pharmaceuticals plc | 10,570,000,000 | -329,700,000 | 3,090,000,000 | 0.00 | 2.58 | 9.29 | - | - | 17.88 | 1.53 | -8.30% | -2.90% |
| KalVista Pharmaceuticals, Inc. | 341,110,000 | -73,200,000 | 0 | 0.00 | 1.60 | 7.76 | - | - | 1.75 | 0.00 | -31.20% | -29.30% |
| Chinook Therapeutics, Inc. | 884,220,000 | -102,900,000 | 51,600,000 | 0.00 | 1.74 | 4.94 | - | - | 3.08 | 0.00 | -31.20% | -23.50% |
| KemPharm, Inc. | 150,890,000 | -62,900,000 | 28,700,000 | 0.00 | 1.29 | 3.46 | - | - | 1.34 | 0.00 | -53.10% | -50.40% |
| Kiniksa Pharmaceuticals, Ltd. | 767,670,000 | -157,900,000 | 38,500,000 | 0.00 | 3.80 | 2.42 | - | - | 4.21 | 0.00 | -69.80% | -58.70% |
| Kinnate Biopharma Inc. | 406,450,000 | -89,800,000 | 0 | 0.00 | 1.19 | 5.40 | - | - | 1.61 | 0.00 | -25.60% | -23.30% |
| Karyopharm Therapeutics Inc. | 565,580,000 | -124,100,000 | 209,800,000 | 0.00 | 0.00 | 2.73 | - | - | 2.47 | 0.00 | 151.10% | -44.30% |
| Kronos Bio, Inc. | 336,720,000 | -151,100,000 | 0 | 0.00 | 0.89 | 5.58 | - | - | 0.99 | 0.00 | -37.50% | -33.60% |
| Keros Therapeutics, Inc. | 1,490,000,000 | -58,700,000 | 20,100,000 | 0.00 | 5.66 | 9.04 | - | - | 6.49 | 0.00 | -24.80% | -23.80% |
| Karuna Therapeutics, Inc. | 4,090,000,000 | -143,800,000 | 37,000,000 | 0.00 | 7.54 | 15.40 | - | - | 8.28 | 0.00 | -26.60% | -25.70% |
| Kura Oncology, Inc. | 1,100,000,000 | -130,500,000 | 0 | 0.00 | 2.01 | 7.20 | - | - | 2.13 | 0.00 | -23.90% | -22.70% |
| Kazia Therapeutics Limited | 106,430,000 | -11,100,000 | 11,200,000 | 0.00 | 5.15 | 0.77 | - | - | 9.50 | 0.00 | -55.30% | -36.50% |
| Kezar Life Sciences, Inc. | 866,790,000 | -54,600,000 | 0 | 0.00 | 3.97 | 3.35 | - | - | 4.16 | 0.05 | -37.20% | -34.10% |
| Landos Biopharma, Inc. | 50,670,000 | -38,400,000 | 18,000,000 | 0.00 | 0.59 | 2.01 | - | - | 0.56 | 0.00 | -40.80% | -36.00% |
| Longboard Pharmaceuticals, Inc. | 80,230,000 | -27,800,000 | 0 | 0.00 | 0.76 | 6.17 | - | - | 0.75 | 0.00 | -24.60% | -23.70% |
| 4D pharma plc | 90,380,000 | 0 | 460,000 | 0.00 | 2.28 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Legend Biotech Corporation | 6,340,000,000 | -386,200,000 | 89,800,000 | 0.00 | 12.17 | 5.45 | - | - | 7.17 | 0.26 | -124.20% | -45.10% |
| Lexaria Bioscience Corp. | 20,950,000 | -7,200,000 | 300,000 | 0.00 | 1.57 | 1.31 | - | - | 2.33 | 0.00 | -61.20% | -60.90% |
| Ligand Pharmaceuticals Incorporated | 1,770,000,000 | 57,100,000 | 277,100,000 | 29.94 | 2.02 | 19.15 | - | - | 5.18 | 0.39 | 7.20% | 4.50% |
| Longeveron Inc. | 243,440,000 | -17,000,000 | 1,300,000 | 0.00 | 6.59 | 1.78 | - | - | 6.94 | 0.00 | -61.50% | -51.60% |
| Lixte Biotechnology Holdings, Inc. | 19,810,000 | -6,700,000 | 0 | 0.00 | 12.89 | 0.28 | - | - | 4.13 | 0.00 | -236.50% | -101.30% |
| Liminal BioSciences Inc. | 25,860,000 | -35,300,000 | 500,000 | 0.00 | 0.73 | 2.67 | - | - | 0.30 | 1.42 | 68.50% | 11.50% |
| Leap Therapeutics, Inc. | 138,740,000 | -40,600,000 | 1,500,000 | 0.00 | 1.17 | 1.23 | - | - | 1.21 | 0.00 | -55.40% | -49.20% |
| Larimar Therapeutics, Inc. | 59,670,000 | -50,600,000 | 0 | 0.00 | 0.97 | 3.99 | - | - | 0.85 | 0.00 | -71.60% | -59.50% |
| Lantern Pharma Inc. | 67,830,000 | -12,400,000 | 0 | 0.00 | 1.02 | 6.79 | - | - | 0.96 | 0.00 | -16.00% | -15.60% |
| Lumos Pharma, Inc. | 72,030,000 | -30,400,000 | 200,000 | 0.00 | 0.78 | 10.88 | - | - | 0.76 | 0.00 | -31.00% | -27.60% |
| Lexicon Pharmaceuticals, Inc. | 336,940,000 | -87,800,000 | 300,000 | 0.00 | 2.66 | 0.52 | - | - | 3.88 | 0.00 | -65.00% | -52.10% |
| Lyell Immunopharma, Inc. | 1,440,000,000 | -250,200,000 | 10,700,000 | 0.00 | 1.48 | 2.34 | - | - | 2.33 | 0.00 | -38.40% | -22.60% |
| Merrimack Pharmaceuticals, Inc. | 81,890,000 | -3,100,000 | 0 | 0.00 | 5.35 | 0.98 | - | - | 5.77 | 0.00 | - | - |
| Mustang Bio, Inc. | 87,900,000 | -66,400,000 | 0 | 0.00 | 0.67 | 1.01 | - | - | 0.80 | 0.00 | -52.80% | -48.70% |
| Moleculin Biotech, Inc. | 54,000,000 | -15,900,000 | 0 | 0.00 | 0.65 | 2.36 | - | - | 0.76 | 0.00 | -19.10% | -17.40% |
| Seres Therapeutics, Inc. | 525,059,999 | -65,599,999 | 144,900,000 | 0.00 | 3.73 | 2.95 | - | - | 1.81 | 0.19 | -47.50% | -19.80% |
| Madrigal Pharmaceuticals, Inc. | 1,400,000,000 | -241,800,000 | 0 | 0.00 | 6.86 | 15.24 | - | - | 5.16 | 0.00 | -100.50% | -79.60% |
| Medicenna Therapeutics Corp. | 82,150,000 | -25,200,000 | 0 | 0.00 | 2.64 | 0.33 | - | - | 3.51 | 0.00 | -84.70% | -74.20% |
| MEI Pharma, Inc. | 72,380,000 | -54,700,000 | 44,100,000 | 0.00 | 0.93 | 1.45 | - | - | 0.39 | 0.00 | -111.90% | -29.30% |
| MacroGenics, Inc. | 528,000,000 | -202,100,000 | 77,400,000 | 0.00 | 2.10 | 3.78 | - | - | 2.17 | 0.00 | -67.30% | -50.90% |
| Magenta Therapeutics, Inc. | 111,270,000 | -71,100,000 | 0 | 0.00 | 0.57 | 2.67 | - | - | 0.63 | 0.00 | -41.00% | -37.40% |
| Mirum Pharmaceuticals, Inc. | 831,720,000 | -84,000,000 | 19,100,000 | 0.00 | 6.54 | 4.85 | - | - | 5.31 | 0.00 | -82.70% | -33.60% |
| Milestone Pharmaceuticals Inc. | 215,350,000 | -42,900,000 | 15,000,000 | 0.00 | 2.63 | 3.71 | - | - | 1.89 | 0.00 | -33.50% | -31.90% |
| MannKind Corporation | 893,600,000 | -80,900,000 | 75,400,000 | 0.00 | 0.00 | 0.77 | - | - | 4.38 | 0.00 | 43.10% | -28.60% |
| MediciNova, Inc. | 152,510,000 | -10,100,000 | 4,000,000 | 0.00 | 1.71 | 1.37 | - | - | 2.14 | 0.00 | -11.50% | -11.00% |
| Monopar Therapeutics Inc. | 29,550,000 | -9,100,000 | 0 | 0.00 | 1.56 | 1.61 | - | - | 1.46 | 0.00 | -41.10% | -39.00% |
| MorphoSys AG | 856,620,000 | -557,500,000 | 194,600,000 | 0.00 | 3.07 | 7.48 | - | - | 0.80 | 1.33 | -101.70% | -23.70% |
| Morphic Holding, Inc. | 1,290,000,000 | -95,500,000 | 19,800,000 | 0.00 | 3.27 | 9.45 | - | - | 3.15 | 0.00 | -27.20% | -21.70% |
| Mereo BioPharma Group plc | 77,860,000 | 0 | 36,460,000 | 0.00 | 0.88 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Mersana Therapeutics, Inc. | 355,290,000 | -170,100,000 | 40,000 | 0.00 | 2.37 | 0.00 | - | - | 0.00 | 0.21 | -101.40% | -73.50% |
| Mirati Therapeutics, Inc. | 4,290,000,000 | -581,800,000 | 72,100,000 | 0.00 | 2.71 | 24.51 | - | - | 2.88 | 0.00 | -47.80% | -41.70% |
| Merus N.V. | 1,050,000,000 | -66,800,000 | 49,100,000 | 0.00 | 2.99 | 8.93 | - | - | 2.56 | 0.00 | -27.30% | -16.80% |
| Maravai LifeSciences Holdings, Inc. | 8,620,000,000 | 182,000,000 | 799,200,000 | 21.48 | 13.87 | 2.13 | - | - | 15.64 | 1.68 | 78.70% | 10.80% |
| Molecular Templates, Inc. | 125,700,000 | -83,000,000 | 38,700,000 | 0.00 | 1.67 | 2.22 | - | - | 0.88 | 0.00 | -96.70% | -36.60% |
| Midatech Pharma plc | 16,950,000 | -10,300,000 | 800,000 | 0.00 | 2.20 | 0.28 | - | - | 3.08 | 0.22 | -91.70% | -52.00% |
| Myovant Sciences Ltd. | 1,030,000,000 | -228,100,000 | 198,000,000 | 0.00 | 0.00 | 5.22 | - | - | 1.96 | 0.00 | 58.10% | -33.30% |
| NeuBase Therapeutics, Inc. | 46,550,000 | -29,100,000 | 0 | 0.00 | 0.99 | 1.44 | - | - | 0.98 | 0.00 | -62.70% | -53.30% |
| Nanobiotix S.A. | 232,860,000 | 0 | 2,380,000 | 0.00 | 5.62 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| NuCana plc | 46,600,000 | -51,000,000 | 0 | 0.00 | 0.44 | 1.68 | - | - | 0.50 | 0.01 | -44.40% | -40.10% |
| NexImmune, Inc. | 70,710,000 | -51,300,000 | 0 | 0.00 | 0.71 | 3.03 | - | - | 0.86 | 0.00 | -49.90% | -46.90% |
| NGM Biopharmaceuticals, Inc. | 1,260,000,000 | -120,300,000 | 77,900,000 | 0.00 | 3.52 | 4.42 | - | - | 3.43 | 0.00 | -32.90% | -28.50% |
| Nektar Therapeutics | 898,450,000 | -523,799,999 | 101,900,000 | 0.00 | 1.29 | 3.86 | - | - | 1.22 | 0.00 | -62.00% | -40.10% |
| Nkarta, Inc. | 667,930,000 | -86,100,000 | 0 | 0.00 | 2.46 | 6.67 | - | - | 2.81 | 0.00 | -30.90% | -28.70% |
| NLS Pharmaceutics AG | 21,760,000 | -11,900,000 | 0 | 0.00 | 20.55 | 0.25 | - | - | 4.03 | 0.00 | 414.60% | -300.80% |
| NanoViricides, Inc. | 21,380,000 | -8,700,000 | 0 | 0.00 | 0.74 | 1.38 | - | - | 1.24 | 0.00 | -29.90% | -29.30% |
| Novan, Inc. | 55,640,000 | -29,700,000 | 3,000,000 | 0.00 | 2.91 | 2.39 | - | - | 1.18 | 0.00 | -152.90% | -44.10% |
| NeuroBo Pharmaceuticals, Inc. | 23,180,000 | -15,300,000 | 0 | 0.00 | 1.39 | 0.54 | - | - | 1.41 | 0.00 | -141.00% | -122.90% |
| Nurix Therapeutics, Inc. | 620,430,000 | -135,500,000 | 34,400,000 | 0.00 | 1.88 | 5.40 | - | - | 2.38 | 0.00 | -38.10% | -28.10% |
| NRx Pharmaceuticals, Inc. | 151,920,000 | -348,900,000 | 0 | 0.00 | 5.06 | 0.33 | - | - | 5.50 | 0.02 | - | - |
| Nuvation Bio Inc. | 1,250,000,000 | -86,800,000 | 0 | 0.00 | 1.57 | 3.42 | - | - | 1.63 | 0.00 | -11.20% | -10.80% |
| Nuvalent, Inc. | 607,650,000 | -46,300,000 | 0 | 0.00 | 1.95 | 5.43 | - | - | 2.11 | 0.00 | -37.10% | -24.40% |
| NextCure, Inc. | 136,390,000 | -69,400,000 | 0 | 0.00 | 0.56 | 7.55 | - | - | 0.62 | 0.00 | -27.10% | -26.00% |
| ObsEva SA | 125,170,000 | -58,400,000 | 20,100,000 | 0.00 | 3.85 | 0.69 | - | - | 2.29 | 0.83 | -139.30% | -61.00% |
| Ocular Therapeutix, Inc. | 318,980,000 | -6,600,000 | 43,500,000 | 0.00 | 3.40 | 2.01 | - | - | 1.94 | 0.58 | -7.70% | -2.90% |
| Ocuphire Pharma, Inc. | 52,200,000 | -56,700,000 | 600,000 | 0.00 | 2.06 | 1.21 | - | - | 2.11 | 0.02 | -301.70% | -261.70% |
| Olema Pharmaceuticals, Inc. | 137,800,000 | -71,100,000 | 0 | 0.00 | 0.43 | 6.42 | - | - | 0.48 | 0.00 | -23.20% | -22.60% |
| Omeros Corporation | 284,870,000 | -191,500,000 | 90,520,000 | 0.00 | 11.39 | 2.39 | - | - | 1.81 | 13.21 | -109.90% | 91.50% |
| Oncorus, Inc. | 35,640,000 | -64,800,000 | 0 | 0.00 | 0.26 | 4.49 | - | - | 0.29 | 0.00 | -42.00% | -30.70% |
| Oncternal Therapeutics, Inc. | 53,700,000 | -31,300,000 | 4,300,000 | 0.00 | 0.57 | 1.71 | - | - | 0.59 | 0.00 | -31.90% | -30.10% |
| Oncolytics Biotech Inc. | 82,610,000 | -20,900,000 | 0 | 0.00 | 2.63 | 0.54 | - | - | 2.52 | 0.02 | -61.90% | -50.40% |
| Onconova Therapeutics, Inc. | 32,000,000 | -16,200,000 | 200,000 | 0.00 | 0.66 | 2.50 | - | - | 0.58 | 0.00 | -39.00% | -31.00% |
| Opiant Pharmaceuticals, Inc. | 104,550,000 | 3,000,000 | 47,800,000 | 45.37 | 2.24 | 9.84 | - | - | 2.08 | 0.45 | -3.00% | -1.80% |
| Orgenesis Inc. | 81,650,000 | -18,100,000 | 35,500,000 | 0.00 | 1.94 | 0.21 | - | - | 14.85 | 0.28 | -38.50% | -25.50% |
| ORIC Pharmaceuticals, Inc. | 160,820,000 | -78,700,000 | 0 | 0.00 | 0.56 | 5.76 | - | - | 0.68 | 0.00 | -28.70% | -27.00% |
| Oramed Pharmaceuticals Inc. | 249,220,000 | -28,300,000 | 2,900,000 | 0.00 | 1.31 | 3.46 | - | - | 1.70 | 0.00 | -24.30% | -22.20% |
| Otonomy, Inc. | 129,320,000 | -51,200,000 | 100,000 | 0.00 | 2.79 | 1.35 | - | - | 1.67 | 0.30 | -80.20% | -50.00% |
| Ovid Therapeutics Inc. | 221,710,000 | 119,800,000 | 208,400,000 | 1.66 | 1.11 | 0.00 | - | - | 0.00 | 0.00 | 59.60% | 55.90% |
| Panbela Therapeutics, Inc. | 25,200,000 | -10,100,000 | 0 | 0.00 | 2.33 | 0.84 | - | - | 2.12 | 0.00 | -109.10% | -92.40% |
| Puma Biotechnology, Inc. | 117,880,000 | -29,100,000 | 253,200,000 | 0.00 | 0.00 | 1.95 | - | - | 1.44 | 0.00 | -358.10% | -12.00% |
| Processa Pharmaceuticals, Inc. | 51,620,000 | -11,400,000 | 0 | 0.00 | 1.73 | 0.90 | - | - | 3.13 | 0.00 | -40.40% | -38.10% |
| PDS Biotechnology Corporation | 161,940,000 | -16,900,000 | 0 | 0.00 | 2.41 | 2.15 | - | - | 2.48 | 0.00 | -29.60% | -27.70% |
| Precigen, Inc. | 326,950,000 | -96,800,000 | 103,900,000 | 0.00 | 2.94 | 0.56 | - | - | 2.84 | 1.71 | -64.40% | -23.80% |
| Pharming Group N.V. | 544,850,000 | 0 | 172,910,000 | 28.43 | 3.34 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| PhaseBio Pharmaceuticals, Inc. | 64,150,000 | -131,100,000 | 10,800,000 | 0.00 | 0.00 | 0.91 | - | - | 1.53 | 0.00 | 340.20% | -154.30% |
| Phathom Pharmaceuticals, Inc. | 558,280,000 | -143,900,000 | 0 | 0.00 | 6.02 | 4.47 | - | - | 3.05 | 1.24 | -121.90% | -65.50% |
| Pharvaris N.V. | 574,430,000 | -46,300,000 | 0 | 0.00 | 1.71 | 6.72 | - | - | 2.53 | 0.00 | -19.50% | -18.80% |
| Pieris Pharmaceuticals, Inc. | 246,890,000 | -45,700,000 | 31,400,000 | 0.00 | 4.51 | 0.00 | - | - | 0.00 | 0.00 | -96.50% | -31.10% |
| Pliant Therapeutics, Inc. | 255,640,000 | -97,300,000 | 7,600,000 | 0.00 | 1.35 | 5.84 | - | - | 1.27 | 0.04 | -41.90% | -39.40% |
| PMV Pharmaceuticals, Inc. | 730,020,000 | -57,800,000 | 0 | 0.00 | 2.43 | 6.74 | - | - | 2.46 | 0.00 | -17.50% | -16.70% |
| POINT Biopharma Global Inc. | 929,410,000 | -45,900,000 | 0 | 0.00 | 3.29 | 2.38 | - | - | 3.89 | 0.00 | -21.90% | -20.90% |
| Purple Biotech Ltd. | 54,290,000 | 0 | 0 | 0.00 | 0.77 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Praxis Precision Medicines, Inc. | 382,440,000 | -167,100,000 | 0 | 0.00 | 1.58 | 6.36 | - | - | 1.39 | 0.00 | -58.30% | -53.50% |
| Pardes Biosciences, Inc. | 543,180,000 | -38,500,000 | 0 | 0.00 | 1.77 | 3.73 | - | - | 2.02 | 0.00 | - | - |
| Prelude Therapeutics Incorporated | 274,100,000 | -111,700,000 | 0 | 0.00 | 0.85 | 5.57 | - | - | 0.94 | 0.00 | -34.70% | -33.00% |
| ProQR Therapeutics N.V. | 55,180,000 | -66,800,000 | 2,600,000 | 0.00 | 0.44 | 2.79 | - | - | 0.27 | 0.53 | -60.10% | -37.40% |
| Prothena Corporation plc | 1,670,000,000 | 67,000,000 | 200,600,000 | 30.42 | 3.33 | 11.54 | - | - | 2.88 | 0.00 | 18.10% | 13.00% |
| Paratek Pharmaceuticals, Inc. | 125,300,000 | -59,100,000 | 130,199,999 | 0.00 | 0.00 | 1.77 | - | - | 1.31 | 0.00 | 52.40% | -33.50% |
| Provention Bio, Inc. | 371,480,000 | -114,400,000 | 1,400,000 | 0.00 | 3.21 | 1.44 | - | - | 3.91 | 0.00 | -78.00% | -66.30% |
| PTC Therapeutics, Inc. | 3,080,000,000 | -523,900,000 | 538,600,000 | 0.00 | 2007.50 | 10.08 | - | - | 3.98 | 848.86 | -351.90% | -25.80% |
| Protagonist Therapeutics, Inc. | 953,910,000 | -125,600,000 | 27,400,000 | 0.00 | 3.02 | 6.44 | - | - | 2.92 | 0.00 | -40.30% | -35.30% |
| Qualigen Therapeutics, Inc. | 22,700,000 | -17,900,000 | 5,700,000 | 0.00 | 1.16 | 0.47 | - | - | 1.30 | 0.00 | -128.10% | -84.40% |
| uniQure N.V. | 818,790,000 | 329,600,000 | 524,000,000 | 2.34 | 1.27 | 11.09 | - | - | 1.47 | 0.17 | 64.30% | 48.30% |
| Rain Therapeutics Inc. | 122,820,000 | -51,400,000 | 0 | 0.00 | 0.90 | 5.08 | - | - | 0.88 | 0.00 | -51.60% | -38.30% |
| Rani Therapeutics Holdings, Inc. | 638,630,000 | -8,300,000 | 2,700,000 | 0.00 | 13.51 | 2.41 | - | - | 5.44 | 0.00 | 23.20% | -7.90% |
| RAPT Therapeutics, Inc. | 613,290,000 | -69,200,000 | 3,800,000 | 0.00 | 2.99 | 5.82 | - | - | 3.23 | 0.00 | -39.70% | -36.80% |
| Ultragenyx Pharmaceutical Inc. | 5,510,000,000 | -454,000,000 | 351,400,000 | 0.00 | 5.63 | 10.17 | - | - | 7.44 | 0.00 | -46.80% | -29.70% |
| Rocket Pharmaceuticals, Inc. | 875,270,000 | -169,100,000 | 0 | 0.00 | 1.73 | 5.40 | - | - | 2.25 | 0.05 | -35.40% | -31.60% |
| Arcus Biosciences, Inc. | 2,210,000,000 | 52,800,000 | 382,900,000 | 0.00 | 2.29 | 6.16 | - | - | 4.43 | 0.00 | 8.00% | 5.00% |
| Regeneron Pharmaceuticals, Inc. | 78,360,000,000 | 8,080,000,000 | 16,070,000,000 | 9.58 | 3.91 | 50.17 | - | - | 13.76 | 0.14 | 51.20% | 36.60% |
| Reata Pharmaceuticals, Inc. | 1,120,000,000 | -297,400,000 | 11,500,000 | 0.00 | 5.72 | 15.44 | - | - | 1.89 | 0.00 | -105.70% | -38.90% |
| Rigel Pharmaceuticals, Inc. | 469,450,000 | -17,900,000 | 149,200,000 | 0.00 | 14.72 | 0.71 | - | - | 3.76 | 0.65 | -31.60% | -9.30% |
| Rallybio Corporation | 329,630,000 | -47,000,000 | 0 | 0.00 | 1.74 | 5.41 | - | - | 1.88 | 0.00 | -31.40% | -30.10% |
| Avidity Biosciences, Inc. | 907,640,000 | -118,000,000 | 9,300,000 | 0.00 | 2.18 | 7.86 | - | - | 2.24 | 0.00 | -35.60% | -32.40% |
| TransCode Therapeutics, Inc. Common Stock | 37,750,000 | -6,800,000 | 0 | 0.00 | 1.77 | 1.54 | - | - | 1.81 | 0.00 | - | - |
| Reneo Pharmaceuticals, Inc. | 62,990,000 | -39,800,000 | 0 | 0.00 | 0.39 | 5.56 | - | - | 0.43 | 0.00 | -37.70% | -27.30% |
| Royalty Pharma plc | 26,720,000,000 | 619,700,000 | 2,290,000,000 | 41.24 | 3.16 | 4.44 | 0.68 | 1.61% | 9.53 | 0.00 | 11.20% | 3.70% |
| Repare Therapeutics Inc. | 552,020,000 | -106,900,000 | 7,600,000 | 0.00 | 1.80 | 7.84 | - | - | 1.65 | 0.00 | -41.90% | -32.30% |
| Revance Therapeutics, Inc. | 1,270,000,000 | -281,300,000 | 77,800,000 | 0.00 | 17.35 | 3.08 | - | - | 5.62 | 4.10 | -181.70% | -46.30% |
| Reviva Pharmaceuticals Holdings, Inc. | 33,330,000 | -7,900,000 | 0 | 0.00 | 1.22 | 2.14 | - | - | 1.00 | 0.00 | - | - |
| Prometheus Biosciences, Inc. | 1,170,000,000 | -90,200,000 | 3,100,000 | 0.00 | 4.59 | 6.07 | - | - | 4.56 | 0.00 | -33.40% | -30.30% |
| Rhythm Pharmaceuticals, Inc. | 415,770,000 | -69,600,000 | 3,200,000 | 0.00 | 1.43 | 5.72 | - | - | 1.41 | 0.00 | -20.80% | -18.60% |
| Rezolute, Inc. | 56,990,000 | -30,600,000 | 0 | 0.00 | 0.86 | 4.65 | - | - | 0.74 | 0.23 | -88.10% | -61.90% |
| Sage Therapeutics, Inc. | 2,069,999,999 | -457,900,000 | 6,300,000 | 0.00 | 1.13 | 27.90 | - | - | 1.19 | 0.00 | -24.40% | -23.30% |
| Cassava Sciences, Inc. | 884,790,000 | -32,400,000 | 0 | 0.00 | 3.25 | 5.44 | - | - | 3.79 | 0.00 | -12.00% | -11.70% |
| scPharmaceuticals Inc. | 134,940,000 | -28,000,000 | 0 | 0.00 | 1.42 | 2.76 | - | - | 1.79 | 0.30 | -42.50% | -31.10% |
| Seelos Therapeutics, Inc. | 78,940,000 | -66,000,000 | 0 | 0.00 | 1.27 | 0.69 | - | - | 1.00 | 0.33 | -111.10% | -89.20% |
| Selecta Biosciences, Inc. | 126,380,000 | -25,700,000 | 85,100,000 | 0.00 | 4.70 | 0.90 | - | - | 0.99 | 1.14 | 513.70% | -15.00% |
| SIGA Technologies, Inc. | 513,650,000 | 69,500,000 | 133,699,999 | 7.56 | 2.84 | 1.35 | - | - | 4.98 | 0.00 | 53.40% | 44.60% |
| Sio Gene Therapies Inc. | 44,270,000 | -61,900,000 | 0 | 0.00 | 0.43 | 0.00 | - | - | 0.00 | 0.00 | -33.60% | -30.60% |
| Sol-Gel Technologies Ltd. | 153,000,000 | 3,200,000 | 31,300,000 | 78.16 | 2.83 | 1.92 | - | - | 3.53 | 0.00 | 7.00% | 5.80% |
| SELLAS Life Sciences Group, Inc. | 54,930,000 | -20,700,000 | 7,600,000 | 0.00 | 2.39 | 1.19 | - | - | 2.57 | 0.00 | -75.90% | -55.80% |
| Summit Therapeutics Inc. | 196,980,000 | -88,600,000 | 1,800,000 | 0.00 | 2.27 | 0.70 | - | - | 2.74 | 0.00 | -95.90% | -67.10% |
| Syndax Pharmaceuticals, Inc. | 963,050,000 | 24,900,000 | 139,700,000 | 70.04 | 2.18 | 7.77 | - | - | 2.15 | 0.05 | 9.50% | 8.10% |
| Synaptogenix, Inc. | 44,340,000 | -12,600,000 | 0 | 0.00 | 1.33 | 5.05 | - | - | 1.30 | 0.00 | -44.80% | -43.00% |
| Sensei Biotherapeutics, Inc. | 59,200,000 | -36,800,000 | 0 | 0.00 | 0.38 | 4.57 | - | - | 0.40 | 0.02 | -23.10% | -22.40% |
| Spectrum Pharmaceuticals, Inc. | 158,690,000 | -158,400,000 | 0 | 0.00 | 3.23 | 0.61 | - | - | 1.58 | 0.00 | -177.20% | -103.40% |
| Spruce Biosciences, Inc. | 49,050,000 | -42,300,000 | 0 | 0.00 | 0.41 | 3.57 | - | - | 0.55 | 0.04 | -33.70% | -30.30% |
| Spero Therapeutics, Inc. | 194,690,000 | -89,800,000 | 18,300,000 | 0.00 | 2.02 | 4.15 | - | - | 1.33 | 0.55 | -87.70% | -62.00% |
| Sarepta Therapeutics, Inc. | 7,090,000,000 | -418,800,000 | 701,900,000 | 0.00 | 7.10 | 22.88 | - | - | 3.35 | 1.18 | -69.30% | -14.80% |
| Sierra Oncology, Inc. | 1,290,000,000 | -94,700,000 | 200,000 | 0.00 | 8.69 | 4.42 | - | - | 12.35 | 0.00 | -100.50% | -90.50% |
| Statera Biopharma, Inc. | 12,210,000 | -25,300,000 | 200,000 | 0.00 | 0.08 | 0.17 | - | - | 1.30 | 0.22 | -113.10% | -78.10% |
| Stoke Therapeutics, Inc. | 695,110,000 | -85,800,000 | 0 | 0.00 | 2.95 | 5.51 | - | - | 3.16 | 0.00 | -34.90% | -33.10% |
| Satsuma Pharmaceuticals, Inc. | 135,680,000 | -51,200,000 | 0 | 0.00 | 1.32 | 2.91 | - | - | 1.46 | 0.01 | -42.40% | -40.00% |
| Shattuck Labs, Inc. | 160,520,000 | -45,000,000 | 30,000,000 | 0.00 | 0.61 | 6.60 | - | - | 0.60 | 0.00 | -16.20% | -14.20% |
| Savara Inc. | 144,810,000 | -43,000,000 | 0 | 0.00 | 1.16 | 1.39 | - | - | 0.90 | 0.18 | -26.90% | -22.40% |
| Synlogic, Inc. | 139,800,000 | -60,600,000 | 1,800,000 | 0.00 | 0.91 | 1.70 | - | - | 1.09 | 0.00 | -44.40% | -36.80% |
| Syros Pharmaceuticals, Inc. | 50,320,000 | -86,600,000 | 23,500,000 | 0.00 | 0.71 | 2.49 | - | - | 0.39 | 0.48 | -73.50% | -39.10% |
| Theravance Biopharma, Inc. | 748,090,000 | -199,400,000 | 55,300,000 | 0.00 | 0.00 | 2.32 | - | - | 4.31 | 0.00 | 59.70% | -50.40% |
| Terns Pharmaceuticals, Inc. | 57,360,000 | -50,200,000 | 1,000,000 | 0.00 | 0.36 | 6.57 | - | - | 0.35 | 0.00 | -28.50% | -27.30% |
| TFF Pharmaceuticals, Inc. | 144,180,000 | -31,000,000 | 80,000 | 0.00 | 3.50 | 1.26 | - | - | 4.27 | 0.00 | -61.60% | -59.50% |
| TG Therapeutics, Inc. | 1,150,000,000 | -348,100,000 | 6,700,000 | 0.00 | 4.17 | 2.04 | - | - | 3.66 | 0.29 | -101.10% | -76.50% |
| Tango Therapeutics, Inc. | 650,800,000 | -58,200,000 | 37,000,000 | 0.00 | 1.84 | 5.35 | - | - | 1.34 | 0.00 | -22.50% | -17.10% |
| Tempest Therapeutics, Inc. | 20,750,000 | -28,300,000 | 0 | 0.00 | 0.50 | 0.00 | - | - | 0.00 | 0.00 | -74.10% | -45.70% |
| Turning Point Therapeutics, Inc. | 1,710,000,000 | -236,600,000 | 30,800,000 | 0.00 | 1.69 | 18.67 | - | - | 1.74 | 0.00 | -22.90% | -22.00% |
| Travere Therapeutics, Inc. | 1,960,000,000 | -180,100,000 | 227,500,000 | 0.00 | 5.82 | 8.03 | - | - | 3.55 | 0.75 | -55.20% | -23.50% |
| Unicycive Therapeutics, Inc. | 15,780,000 | -10,000,000 | 0 | 0.00 | 0.98 | 1.12 | - | - | 0.95 | 0.00 | -143.70% | -100.30% |
| UroGen Pharma Ltd. | 169,350,000 | -110,800,000 | 48,000,000 | 0.00 | 19.71 | 3.95 | - | - | 1.90 | 0.00 | -256.70% | -87.70% |
| United Therapeutics Corporation | 8,390,000,000 | 475,800,000 | 1,690,000,000 | 18.59 | 2.13 | 42.87 | - | - | 4.34 | 0.20 | 12.80% | 9.70% |
| Vaccitech plc | 220,630,000 | -50,900,000 | 300,000 | 0.00 | 0.55 | 5.19 | - | - | 1.03 | 0.00 | -29.50% | -21.10% |
| VBI Vaccines Inc. | 393,920,000 | -69,800,000 | 600,000 | 0.00 | 2.54 | 0.44 | - | - | 3.24 | 0.00 | -42.80% | -31.60% |
| Vascular Biogenics Ltd. | 112,970,000 | -29,900,000 | 800,000 | 0.00 | 2.07 | 0.68 | - | - | 2.12 | 0.00 | -61.00% | -49.80% |
| Vaccinex, Inc. | 52,510,000 | -22,400,000 | 900,000 | 0.00 | 5.08 | 0.20 | - | - | 6.11 | 0.04 | -241.60% | -112.60% |
| Vera Therapeutics, Inc. | 608,930,000 | -32,600,000 | 0 | 0.00 | 6.50 | 2.77 | - | - | 7.64 | 0.07 | -84.70% | -40.20% |
| Verve Therapeutics, Inc. | 914,560,000 | -120,300,000 | 0 | 0.00 | 2.29 | 6.67 | - | - | 2.54 | 0.00 | -44.90% | -34.90% |
| Vincerx Pharma, Inc. | 60,840,000 | -39,300,000 | 0 | 0.00 | 0.55 | 4.86 | - | - | 0.55 | 0.00 | -52.70% | -39.70% |
| Viracta Therapeutics, Inc. | 124,280,000 | -114,800,000 | 0 | 0.00 | 1.20 | 0.00 | - | - | 0.00 | 0.05 | -109.70% | -93.70% |
| Viking Therapeutics, Inc. | 201,420,000 | -55,000,000 | 0 | 0.00 | 0.95 | 2.47 | - | - | 1.00 | 0.00 | -25.10% | -23.80% |
| Vallon Pharmaceuticals, Inc. | 6,830,000 | -9,300,000 | 0 | 0.00 | 2.28 | 2.13 | - | - | 0.91 | 0.03 | -102.20% | -83.20% |
| Vanda Pharmaceuticals Inc. | 620,420,000 | 33,200,000 | 268,700,000 | 18.51 | 1.19 | 7.53 | - | - | 1.43 | 0.00 | 6.80% | 5.80% |
| Verrica Pharmaceuticals Inc. | 207,210,000 | -35,100,000 | 12,000,000 | 0.00 | 6.14 | 2.46 | - | - | 2.94 | 1.28 | -74.90% | -37.30% |
| Verona Pharma plc | 256,810,000 | -55,600,000 | 40,000,000 | 0.00 | 1.78 | 0.00 | - | - | 0.00 | 0.00 | -34.60% | -27.90% |
| Virpax Pharmaceuticals, Inc. | 22,110,000 | -12,100,000 | 0 | 0.00 | 0.55 | 2.93 | - | - | 0.60 | 0.00 | -50.20% | -44.90% |
| Vertex Pharmaceuticals Incorporated | 73,240,000,000 | 2,340,000,000 | 7,570,000,000 | 30.10 | 6.85 | 27.91 | - | - | 9.73 | 0.05 | 24.80% | 18.60% |
| Verastem, Inc. | 318,940,000 | -71,200,000 | 2,100,000 | 0.00 | 3.16 | 0.50 | - | - | 3.18 | 0.00 | -76.10% | -59.20% |
| VistaGen Therapeutics, Inc. | 305,350,000 | -61,600,000 | 1,500,000 | 0.00 | 3.43 | 0.38 | - | - | 3.65 | 0.00 | -72.80% | -61.10% |
| Wave Life Sciences Ltd. | 159,900,000 | -122,200,000 | 41,000,000 | 0.00 | 3.54 | 1.90 | - | - | 1.06 | 0.00 | -356.80% | -57.10% |
| Xenetic Biosciences, Inc. | 14,320,000 | -5,600,000 | 1,200,000 | 0.00 | 0.72 | 1.26 | - | - | 0.79 | 0.00 | -38.00% | -35.40% |
| XBiotech Inc. | 239,260,000 | -17,400,000 | 18,400,000 | 0.00 | 0.84 | 7.40 | - | - | 1.01 | 0.00 | -5.60% | -5.50% |
| Xenon Pharmaceuticals Inc. | 1,800,000,000 | -77,100,000 | 18,400,000 | 0.00 | 3.39 | 10.11 | - | - | 3.26 | 0.00 | -23.70% | -22.00% |
| Xeris Biopharma Holdings, Inc. | 342,430,000 | -122,700,000 | 49,600,000 | 0.00 | 3.10 | 0.72 | - | - | 3.34 | 0.93 | -312.60% | -65.00% |
| Xencor, Inc. | 1,620,000,000 | 82,600,000 | 275,100,000 | 20.01 | 2.14 | 5.51 | - | - | 4.84 | 0.00 | 12.80% | 11.30% |
| XOMA Corporation | 275,880,000 | 8,000,000 | 38,200,000 | 146.67 | 1.86 | 7.95 | - | - | 2.93 | 0.00 | 7.10% | 5.80% |
| XORTX Therapeutics Inc. | 30,880,000 | -1,700,000 | 0 | 0.00 | 1.27 | 1.05 | - | - | 1.63 | 0.00 | -34.30% | -14.50% |
| XTL Biopharmaceuticals Ltd. | 11,970,000 | 0 | 0 | 0.00 | 3.68 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Y-mAbs Therapeutics, Inc. | 549,900,000 | -55,300,000 | 34,900,000 | 0.00 | 2.69 | 3.66 | - | - | 3.03 | 0.00 | -25.20% | -22.40% |
| Yumanity Therapeutics, Inc. | 14,370,000 | -39,500,000 | 8,000,000 | 0.00 | 0.54 | 3.12 | - | - | 0.39 | 0.57 | -108.20% | -51.60% |
| Zealand Pharma A/S | 548,910,000 | -148,300,000 | 42,600,000 | 0.00 | 3.95 | 4.68 | - | - | 2.64 | 0.85 | -78.90% | -52.10% |
| 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Zai Lab Limited | 4,590,000,000 | -704,500,000 | 144,300,000 | 0.00 | 0.32 | 14.09 | - | - | 3.26 | 0.00 | -49.90% | -44.30% |
| Zentalis Pharmaceuticals, Inc. | 1,190,000,000 | -158,700,000 | 0 | 0.00 | 2.95 | 6.84 | - | - | 3.49 | 0.00 | -50.80% | -42.30% |
| Zymeworks Inc. | 322,250,000 | -211,800,000 | 26,700,000 | 0.00 | 1.06 | 3.99 | - | - | 1.28 | 0.00 | -69.10% | -47.80% |